miR-372 regulates cell cycle and apoptosis of ags human gastric cancer cell line through direct regulation of LATS2

Molecules and Cells
Wha Ja ChoKye-Seong Kim

Abstract

Previously, we have reported tissue- and stage-specific expression of miR-372 in human embryonic stem cells and so far, not many reports speculate the function of this microRNA (miRNA). In this study, we screened various human cancer cell lines including gastric cancer cell lines and found first time that miR-372 is expressed only in AGS human gastric adenocarcinoma cell line. Inhibition of miR-372 using antisense miR-372 oligonucleotide (AS-miR-372) suppressed proliferation, arrested the cell cycle at G2/M phase, and increased apoptosis of AGS cells. Furthermore, AS-miR-372 treatment increased expression of LATS2, while over-expression of miR-372 decreased luciferase reporter activity driven by the 3' untranslated region (3' UTR) of LATS2 mRNA. Over-expression of LATS2 induced changes in AGS cells similar to those in AGS cells treated with AS-miR-372. Taken together, these findings demonstrate an oncogenic role for miR-372 in controlling cell growth, cell cycle, and apoptosis through down-regulation of a tumor suppressor gene, LATS2.

References

Nov 1, 1994·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M Dorée, S Galas
Oct 27, 2001·Science·R C Lee, V Ambros
Mar 8, 2003·The Journal of Biological Chemistry·Yasuhiko KamikuboToshiyuki Hori
Jul 11, 2003·Oncogene·Yunfang LiWufan Tao
Dec 31, 2003·Cell·Benjamin P LewisChristopher B Burge
Jun 9, 2004·Developmental Biology·Mi-Ra SuhKye-Seong Kim
Jun 24, 2004·Nature Reviews. Genetics·Lin He, Gregory J Hannon
Jun 10, 2005·Nature·Lin HeScott M Hammond
Jun 10, 2005·Nature·Jun LuTodd R Golub
Jun 10, 2005·Nature·Kathryn A O'DonnellJoshua T Mendell
Jun 21, 2005·Nature Genetics·Isaac BentwichZvi Bentwich
Sep 6, 2005·Science·Phillip D Zamore, Benjamin Haley
Sep 17, 2005·Proceedings of the National Academy of Sciences of the United States of America·Amelia CimminoCarlo M Croce
Feb 8, 2006·Proceedings of the National Academy of Sciences of the United States of America·Stefano VoliniaCarlo M Croce
Oct 14, 2006·Science·Jiri Bartek, Jiri Lukas
Dec 14, 2006·International Journal of Cancer. Journal International Du Cancer·Wei WuJianjun Chen
Sep 6, 2007·Cell Cycle·Michael CarletonPeter S Linsley
Sep 27, 2007·Molecular Cancer·William C S Cho
Mar 1, 2008·The Lancet Oncology·Wai K LeungUNKNOWN Asia Pacific Working Group on Gastric Cancer
Aug 20, 2008·Molecular and Cellular Biology·Deborah A Greer CardTrevor K Archer
Oct 18, 2008·Circulation Research·Yutaka MatsuiJunichi Sadoshima
Oct 22, 2008·Biochemical and Biophysical Research Communications·Nan Sook LeeKye-Seong Kim
Feb 20, 2009·Journal of Gastroenterology·Yoshimasa SaitoToshifumi Hibi

❮ Previous
Next ❯

Citations

Nov 11, 2011·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Seyed H GhaffariKamran Alimoghaddam
Nov 10, 2013·Nature Communications·Yonatan StelzerNissim Benvenisty
Mar 26, 2010·The Journal of Biological Chemistry·Hyun Hee LeeWha Ja Cho
May 5, 2010·Genes & Development·Bin ZhaoKun-Liang Guan
Jul 2, 2010·The Journal of Clinical Investigation·Chung-Fan LeeLi-Jung Juan
Jan 10, 2013·Diagnostic Pathology·Gang LiGuodong Gao
Dec 4, 2012·International Journal of Molecular Sciences·Ying YinJianmin Si
Mar 20, 2012·Yi chuan = Hereditas·Chuan-Ming Xu, Fu-Sheng Wan
Jun 2, 2011·Journal of Aging Research·Andrea FelicianoMatilde E Lleonart
Jul 26, 2014·Cancer Gene Therapy·Z ZhangA Zang
May 12, 2011·Expert Opinion on Therapeutic Targets·Yanjun XuTianhua Zhou
Feb 18, 2012·Expert Opinion on Therapeutic Targets·Angela M LiuJohn M Luk
Jun 16, 2010·Expert Opinion on Therapeutic Targets·Angela M LiuJohn M Luk
Aug 29, 2014·Expert Review of Anticancer Therapy·Qian MeiWeidong Han
Feb 13, 2016·Diagnostic Cytopathology·Roghayeh SheervalilouNosratollah Zarghami
Feb 26, 2013·Journal of Reproductive Immunology·Diana M Morales-PrietoUdo R Markert
Oct 15, 2010·Journal of Cellular Physiology·Siew Wee ChanWanjin Hong
Jun 4, 2013·Liver International : Official Journal of the International Association for the Study of the Liver·Yun ZhouJianping Zhang
Apr 12, 2012·Journal of Cellular Biochemistry·Lieke GerritsWiljan J A J Hendriks
Jul 28, 2011·Medicinal Research Reviews·Jose A LealMatilde E Lleonart
Aug 28, 2014·Journal of Cellular Biochemistry·Xin ChenJianmin Liu
Apr 1, 2015·Biochemical and Biophysical Research Communications·Mingjun ZhangYongchun Cui
May 13, 2010·Biochemical and Biophysical Research Communications·Qiuling WuKeith A Webster
Apr 8, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Fatemeh Jamshidi-AdeganiMasoud Soleimani
Jun 12, 2012·Biochimica Et Biophysica Acta·Angela M LiuJohn M Luk
Sep 18, 2014·Biochimie·Júlia L F AbrantesCarmen V Ferreira-Halder
Jun 23, 2012·Digestive Diseases·Alexander LinkPeter Malfertheiner
May 5, 2018·Endocrine-related Cancer·Chiara VerdelliSabrina Corbetta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.